| Literature DB >> 27049721 |
Hagai Yanai1, Arie Budovsky1,2, Robi Tacutu1, Thomer Barzilay1, Amir Abramovich1, Rolf Ziesche3, Vadim E Fraifeld1.
Abstract
Wound healing is an inherent feature of any multicellular organism and recent years have brought about a huge amount of data regarding regular and abnormal tissue repair. Despite the accumulated knowledge, modulation of wound healing is still a major biomedical challenge, especially in advanced ages. In order to collect and systematically organize what we know about the key players in wound healing, we created the TiRe (Tissue Repair) database, an online collection of genes and proteins that were shown to directly affect skin wound healing. To date, TiRe contains 397 entries for four organisms: Mus musculus, Rattus norvegicus, Sus domesticus, and Homo sapiens. Analysis of the TiRe dataset of skin wound healing-associated genes showed that skin wound healing genes are (i) over-conserved among vertebrates, but are under-conserved in invertebrates; (ii) enriched in extracellular and immuno-inflammatory genes; and display (iii) high interconnectivity and connectivity to other proteins. The latter may provide potential therapeutic targets. In addition, a slower or faster skin wound healing is indicative of an aging or longevity phenotype only when assessed in advanced ages, but not in the young. In the long run, we aim for TiRe to be a one-station resource that provides researchers and clinicians with the essential data needed for a better understanding of the mechanisms of wound healing, designing new experiments, and the development of new therapeutic strategies. TiRe is freely available online at http://www.tiredb.org.Entities:
Keywords: Gerotarget; aging; database; genes; skin; wound healing
Mesh:
Year: 2016 PMID: 27049721 PMCID: PMC5008274 DOI: 10.18632/oncotarget.8501
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Summary of interventions included in the TiRe database. Each entry represents a single study
| Intervention | Number of entries per species | ||||
|---|---|---|---|---|---|
| 260 | 0 | 0 | 0 | 260 | |
| 47 | 8 | 3 | 1 | 59 | |
| 13 | 0 | 0 | 0 | 13 | |
| 5 | 0 | 0 | 0 | 5 | |
| 15 | 27 | 8 | 12 | 62 | |
| 8 | 6 | 0 | 0 | 14 | |
| 8 | 2 | 0 | 0 | 10 | |
| 2 | 1 | 1 | 1 | 5 | |
Summary of wound healing assays included in the TiRe database
| Intervention | Number of entries per species | ||||
|---|---|---|---|---|---|
| Mus musculus | Rattus norvegicus | Sus domesticus | Homo sapiens | Total | |
| Full-thickness excisional punch | 264 | 16 | 2 | 0 | 282 |
| Full-thickness incision | 36 | 13 | 1 | 0 | 50 |
| Flap | 5 | 15 | 0 | 0 | 20 |
| Clinical trial/case report | 0 | 0 | 0 | 14 | 14 |
| Skin graft | 4 | 3 | 4 | 0 | 11 |
| Partial-Thickness wound | 4 | 0 | 6 | 0 | 10 |
| Burn wound | 2 | 2 | 2 | 0 | 6 |
| Embryonic skin wound | 6 | 0 | 0 | 0 | 6 |
| Ear hole | 5 | 0 | 0 | 0 | 5 |
| Other | 26 | 6 | 0 | 0 | 32 |
Note: over 95% of the indicated studies were performed on the dorsum.
Summary of genes (human orthologs) tested for their effect on skin wound healing in more than one species. Filled box indicates an examined species
| Gene symbol | Gene name | ||||
|---|---|---|---|---|---|
| Fibroblast Growth Factor 2 | |||||
| Platelet derived growth factor, B polypeptide | |||||
| Transforming Growth Factor, Beta 3 | |||||
| Vascular Endothelial Growth Factor A | |||||
| Gap Junction Protein, Alpha 1 | |||||
| Epidermal Growth Factor | |||||
| Adrenomedullin | |||||
| Adrenergic Receptor, Beta 2 | |||||
| Angiotensinogen | |||||
| Complement Component 3 | |||||
| Hemolytic complement | |||||
| Erythropoietin | |||||
| Hepatocyte Growth Factor | |||||
| Insulin-Like Growth Factor 1 | |||||
| Integrin Beta 2 | |||||
| Leptin | |||||
| Matrix Metallopeptidase 8 | |||||
| Nerve growth factor | |||||
| Transforming Growth Factor, Beta 1 | |||||
| Transforming Growth Factor, Beta Receptor Ii | |||||
| Heparanase | |||||
| Ankyrin Repeat Domain 1 | |||||
| Fibroblast Growth Factor 7 | |||||
| Serum amyloid P-component | |||||
| Calreticulin | |||||
| Erb-b2 receptor tyrosine kinase 3 | |||||
| Heat shock protein 90, alpha | |||||
| Lactotransferrin | |||||
| Vitronectin | |||||
| Colony Stimulating Factor 2 | |||||
| Coagulation Factor Xiii, A1 Subunit | |||||
| Fibroblast Growth Factor 10 |
Note: the majority of effects on wound healing were concordant across species.
Figure 1Evolutionary conservation of skin wound healing-associated genes
Each dot represents the percentage of orthologs between humans and a given species (in descending order by % of orthology). A total of 205 species from all kingdoms of life are presented (for a full list of species and conservation data see Suppl. Table 1). Black triangle - WHAGs (n = 329); grey circle - entire proteome control (n = 20,834). Chi square (χ2) goodness of fit is significant (p < 0.05) for all but 3 of 205 species (see Suppl. Table 1). Evaluation was performed for a score of 1.0.
Figure 2Enrichment analysis
A. Cellular component enrichment for all WHAGs. B. KEGG pathway enrichment for all WHAGs. C. KEGG pathway enrichment for WHAGs that are evolutionary conserved only in vertebrates (see Suppl. Table 1). Enrichment analysis was performed with Enrichr [33] against the Gene Ontology and the KEGG databases. All enrichments presented were statistically significant (adjusted p < 0.05). The presented combined score is the multiplication of the p-value (Fisher exact test) and the z-score of the deviation from the expected rank (for more details see:http://amp.pharm.mssm.edu/Enrichr/).
Figure 3Protein-protein interaction network of skin wound healing genes
Depicted in the figure is the largest continuous component of the wound healing network with the most enriched signaling pathways (See Figure 2). Included are also 27 WHAGs connected to the WH network only through the enriched pathways. Genes (N = 231) are depicted with green circles and KEGG pathways (N = 9) with yellow rectangles. The enriched pathways include a total of 114 WHAGs, with several genes belonging to multiple pathways. Depicted are 188 Gene-pathways connections and 566 gene-gene interactions.
Selected partners of WHAGs with a strong potential to modulate wound healing
| Gene symbol | Gene name | Number of interactions with WH genes | Involvement in WH pathways |
|---|---|---|---|
| activin A receptor type IIB | 10 | Cytokine-cytokine receptor interaction | |
| conserved helix-loop-helix ubiquitous kinase | 15 | MAPK signaling pathway; Toll-like receptor signaling pathway | |
| CREB binding protein | 30 | Adherens junction; Jak-STAT signaling pathway | |
| E1A binding protein p300 | 40 | Adherens junction; Jak-STAT signaling pathway | |
| inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 16 | MAPK signaling pathway; Toll-like receptor signaling pathway | |
| integrin subunit alpha 5 | 8 | Focal adhesion; ECM-receptor interaction; Hematopoietic cell lineage; Regulation of actin cytoskeleton | |
| Janus kinase 2 | 15 | Jak-STAT signaling pathway | |
| mitogen-activated protein kinase 8 | 18 | MAPK signaling pathway; ErbB signaling pathway; Focal adhesion; Toll-like receptor signaling pathway; Fc epsilon RI signaling pathway | |
| protein inhibitor of activated STAT 2 | 14 | Jak-STAT signaling pathway | |
| phosphoinositide-3-kinase regulatory subunit 1 | 16 | ErbB signaling pathway; VEGF signaling pathway; Focal adhesion; Toll-like receptor signaling pathway; Jak-STAT signaling pathway; Fc epsilon RI signaling pathway; Leukocyte transendothelial migration; Regulation of actin cytoskeleton | |
| prostaglandin E synthase 3 | 13 | Arachidonic acid metabolism; Metabolic pathways | |
| v-rel avian reticuloendotheliosis viral oncogene homolog A | 21 | MAPK signaling pathway; Toll-like receptor signaling pathway; TNF signaling pathway | |
| SRC proto-oncogene, non-receptor tyrosine kinase | 39 | ErbB signaling pathway; VEGF signaling pathway; Focal adhesion; Adherens junction; Regulation of actin cytoskeleton | |
| spleen tyrosine kinase | 16 | Fc epsilon RI signaling pathway |
Gene selection was based on candidate's connectivity with other WHAGs (Fig. 3), using the Hypergeometric Distribution test (p < 1E-9 for all presented genes). For more details see Suppl. Table 2.
Comparison of the effects of genetic interventions on skin wound healing and longevity in mice
| Target gene | Wound healing | Longevity | |||
|---|---|---|---|---|---|
| Type of genetic intervention | Age of wounding (months) | Effect on WH rate | Type of intervention | Effect on lifespan | |
| Knockout | 2 | - | Knockout | Increase | |
| Knockout | 8 | - | Knockout | Decrease | |
| Mutation (LOF) | 2 | + | Mutation (LOF) | Decrease Increase | |
| 12 | - | ||||
| Knockout | 2 | + | Knockout | Decrease | |
| Mutation (LOF) | 2 | - | Mutation (LOF) | Decrease | |
| Knockout | 2 | + | Knockout | Decrease | |
| Mutation (LOF) | 2-3 | - | Mutation (LOF) | Decrease | |
| 11 | - | ||||
| Overexpression | 2 | + | Overexpression | Increase | |
| Knockout | 2 | - | Knockout Overexpression | Increase Decrease | |
| Overexpression | 4 | + | Knockout | Decrease | |
| Knockout | 2-18 | - | Mutation | Increase | |
| Knockout | 2 | - | Knockout | Decrease | |
| Overexpression | 4-5 | = | Overexpression | Increase | |
| 24-25 | + | ||||
| Knockout | 2-3 | - | Knockdown | Decrease | |
| Knockout | N/A | + | Knockout Overexpression | Decrease Increase | |
| Knockout | 2-3 | + | Knockout | Increase | |
| Overexpression | 2-4 | + | Overexpression | Increase | |
| Mutation (EF) | 3 | = | Mutation (EF) | Decrease | |
| 24 | - | ||||
Loss-of-function
Enhanced function
Ectopic expression
For full gene names please refer to the database